These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 11121744)

  • 1. Aggresomes, inclusion bodies and protein aggregation.
    Kopito RR
    Trends Cell Biol; 2000 Dec; 10(12):524-30. PubMed ID: 11121744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic dynein/dynactin mediates the assembly of aggresomes.
    Johnston JA; Illing ME; Kopito RR
    Cell Motil Cytoskeleton; 2002 Sep; 53(1):26-38. PubMed ID: 12211113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein folding, misfolding, and aggregation. Formation of inclusion bodies and aggresomes.
    Markossian KA; Kurganov BI
    Biochemistry (Mosc); 2004 Sep; 69(9):971-84. PubMed ID: 15521811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggresome formation and neurodegenerative diseases: therapeutic implications.
    Olzmann JA; Li L; Chin LS
    Curr Med Chem; 2008; 15(1):47-60. PubMed ID: 18220762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway.
    Olzmann JA; Chin LS
    Autophagy; 2008 Jan; 4(1):85-7. PubMed ID: 17957134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains.
    Hao R; Nanduri P; Rao Y; Panichelli RS; Ito A; Yoshida M; Yao TP
    Mol Cell; 2013 Sep; 51(6):819-28. PubMed ID: 24035499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hook2 contributes to aggresome formation.
    Szebenyi G; Wigley WC; Hall B; Didier A; Yu M; Thomas P; Krämer H
    BMC Cell Biol; 2007 May; 8():19. PubMed ID: 17540036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification and significance of a novel degradation system for polyglutamine aggregates].
    Iwata A
    Rinsho Shinkeigaku; 2013; 53(1):1-8. PubMed ID: 23328059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-3-3 and aggresome formation: implications in neurodegenerative diseases.
    Jia B; Wu Y; Zhou Y
    Prion; 2014; 8(2):173-7. PubMed ID: 24549097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.
    Taylor JP; Tanaka F; Robitschek J; Sandoval CM; Taye A; Markovic-Plese S; Fischbeck KH
    Hum Mol Genet; 2003 Apr; 12(7):749-57. PubMed ID: 12651870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opinion: What is the role of protein aggregation in neurodegeneration?
    Ross CA; Poirier MA
    Nat Rev Mol Cell Biol; 2005 Nov; 6(11):891-8. PubMed ID: 16167052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presenilin-binding protein forms aggresomes in monkey kidney COS-7 cells.
    Namekata K; Nishimura N; Kimura H
    J Neurochem; 2002 Aug; 82(4):819-27. PubMed ID: 12358787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggresomes: a cellular response to misfolded proteins.
    Johnston JA; Ward CL; Kopito RR
    J Cell Biol; 1998 Dec; 143(7):1883-98. PubMed ID: 9864362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hassles with taking out the garbage: aggravating aggresomes.
    Garcia-Mata R; Gao YS; Sztul E
    Traffic; 2002 Jun; 3(6):388-96. PubMed ID: 12010457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of aggresomes with hydrogel-like characteristics by proteasome inhibition.
    Park SH; Lee SE; Jeon JH; Lee JH; Itakura E; Chang S; Choi WH; Lee MJ
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194932. PubMed ID: 36997115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded polyglutamine stretches form an 'aggresome'.
    Shimohata T; Sato A; Burke JR; Strittmatter WJ; Tsuji S; Onodera O
    Neurosci Lett; 2002 May; 323(3):215-8. PubMed ID: 11959423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration.
    Richter-Landsberg C; Leyk J
    Acta Neuropathol; 2013 Dec; 126(6):793-807. PubMed ID: 23912309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibition drives HDAC6-dependent recruitment of tau to aggresomes.
    Guthrie CR; Kraemer BC
    J Mol Neurosci; 2011 Sep; 45(1):32-41. PubMed ID: 21340680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.